Pinocembrin ameliorates post-infarct heart failure through activation of Nrf2/HO-1 signaling pathway.
- DOI
- 10.1186/s10020-021-00363-7
- Published
- 2021 Sep 6
- Container
- Molecular medicine (Cambridge, Mass.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s10020-021-00363-7,
title = {Pinocembrin ameliorates post-infarct heart failure through activation of Nrf2/HO-1 signaling pathway.},
author = {Chen X and Wan W and Guo Y and Ye T and Fo Y and Sun Y and Qu C and Yang B and Zhang C},
year = {2021},
journal = {Molecular medicine (Cambridge, Mass.)},
doi = {10.1186/s10020-021-00363-7},
url = {https://doi.org/10.1186/s10020-021-00363-7}
}RIS
TY - JOUR TI - Pinocembrin ameliorates post-infarct heart failure through activation of Nrf2/HO-1 signaling pathway. AU - Chen X AU - Wan W AU - Guo Y AU - Ye T AU - Fo Y AU - Sun Y AU - Qu C AU - Yang B AU - Zhang C PY - 2021 JO - Molecular medicine (Cambridge, Mass.) DO - 10.1186/s10020-021-00363-7 UR - https://doi.org/10.1186/s10020-021-00363-7 ER -
APA
X, C., W, W., Y, G., T, Y., Y, F., Y, S., C, Q., B, Y., & C, Z. (2021). Pinocembrin ameliorates post-infarct heart failure through activation of Nrf2/HO-1 signaling pathway.. Molecular medicine (Cambridge, Mass.). https://doi.org/10.1186/s10020-021-00363-7
Source records
- pubmed · retrieved 2026-11-10T13:14:13.120Z